Dolophine
Model 3D (JSmol) | |
---|---|
Bioketersediaan | 15 – 20%; subkutaneus[4] 100% intravena[4] |
Pengikatan protein | 85–90%[4] |
Nama dagang | Dolophine, Methadose, lain-lain |
CompTox Dashboard (EPA) | |
IUPHAR/BPS | |
ChEBI | |
Penyingkiran separuh hayat | 15 ke 55 jam[5] |
MedlinePlus | a682134 |
Kekiralan | Campuran rasemik |
Liabilitiketagihan | Tinggi[3] |
Formula | C21H27NO |
AHFS/Drugs.com | Monograph |
PubChem CID | |
ChemSpider |
|
DrugBank |
|
KEGG |
|
ChEMBL | |
Jisim molar | 309.45 g·mol−1 |
Data lesen | |
Kod ATC | |
UNII | |
Kategorikehamilan |
|
Status perundangan |
|
Nombor CAS |
|
ECHA InfoCard | 100.000.907 |
Kaedahpemberian | Mulut, intravena, insuflasi, sublidah, rektum |
Perkumuhan | Kencing, tahi[5] |
Tempoh tindak | Dos tunggal: 4 – 8 jam Jangka panjang: • Pencegahan penarikan: 1 – 2 hari[6] • Pelegaan sakit: 8 – 12 jam[6][7] |
Metabolisme | Hati (berbantu CYP3A4, CYP2B6 dan CYP2D6)[4][5] |
Mula masa tindak | Pantas[6] |